Epiroc AB (publ) (EPI-A)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 252.00 |
|---|---|
| 52-week range | 186.60 – 284.30 |
| Return, 1 month / 3 months | −2.4% / +3.3% |
| Return, 1 year / 3 years | +14.3% / +43.7% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 31.9% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 374.38M SEK |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Epiroc AB is a Swedish industrial company that supplies equipment and services to the mining and rock excavation industries. Its products include drill rigs, rock breakers, loaders and haulers, and tools for construction and demolition work. Customers are mining companies, construction contractors and infrastructure builders around the world. The company also provides spare parts, service and support to keep that machinery running, and it is based in Stockholm, Sweden.
The shares are listed on the Nasdaq Stockholm in Sweden under the code EPI-A, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Epiroc AB (publ) (EPI-A) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 252.00 on 27 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 132 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.3% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -9.4% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.3% | ||
| 6-month return | 3.8% | ||
| 12-month return, skipping the last month | 17.1% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 374.38M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −2.4% |
| 3 months | +3.3% |
| 6 months | +3.8% |
| 1 year | +14.3% |
| 3 years | +43.7% |
| 5 years | +28.1% |
Signals
| 50-day / 200-day average | 258.67 / 252.73 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | SEK 1.9000 |
| 7 May 2026 | SEK 1.9000 |
| 13 Oct 2025 | SEK 1.9000 |
| 9 May 2025 | SEK 1.9000 |
| 21 Oct 2024 | SEK 1.9000 |
| 15 May 2024 | SEK 1.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.